⌘K

Home/Filings/4/0000950170-23-030805

4//SEC Filing

AHMED NADIM 4

Accession 0000950170-23-030805

CIK 0001789972other

View on SEC.gov Company Profile

Filed

Jun 28, 8:00 PM ET

Accepted

Jun 29, 4:59 PM ET

Size

4.7 KB

Accession

0000950170-23-030805

Insider Transaction Report

Form 4

Period: 2023-06-28

Cullinan Oncology, Inc.CGEM

DirectorPresident and CEO

Transactions

Sale
Common Stock
2023-06-28$11.40/sh−759$8,653→ 115,822 total

Footnotes (1)

[F1]Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Cullinan Oncology, Inc.

CIK 0001789972

Entity typeother

Related Parties

1

filerCIK 0001731193

Filing Metadata

Form type: 4
Filed: Jun 28, 8:00 PM ET
Accepted: Jun 29, 4:59 PM ET
Size: 4.7 KB

View on SEC.gov